Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Adocia (ADOCY) Stock Price & Analysis

ADOCY Stock Chart & Stats

$3.38-$0.04(-1.05%)
At close: 4:00 PM EDT
$10$11$1229 Dec28 May
Day’s Range
$3.38 - $3.38
52-Week Range
$2.25 - $10.44
Previous Close
$3.42
Volume
N/A
Average Volume (3M)
0
Market Cap
$74.32M
Enterprise Value
$91.63M
Total Cash (Recent Filing)
$17.25M
Total Debt (Recent Filing)
$8.90M
Price to Earnings (P/E)
―
Beta
1.10
Next Earnings
Sep 20, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Formulation Platform

Adocia’s proprietary formulation focus gives it a technology-centered business model that can be applied across insulin and other injectable biologics. If successfully partnered, the platform may support multiple development opportunities without requiring the company to commercialize every product independently.

Partnering-based Revenue Model

The partnering and licensing model can provide several potential economic streams from successful programs, including upfront payments, milestones, royalties, and reimbursed research. This structure can extend commercial reach while reducing the need for Adocia to build a large direct-sales organization.

Positive Equity And Improved Operating Burn

The improvement in operating cash flow and return to positive equity in 2025 indicate some recovery from earlier financial pressure. Although the balance sheet remains constrained, better burn performance could lengthen funding capacity and provide greater flexibility while clinical and partnering activities progress.

Bears Say

Persistent Unprofitable Operations

Persistent losses and deeply negative margins show that current activities are not covering the company’s cost base. This weak earnings profile limits internally generated funding, increases dependence on successful partnering or financing, and makes sustained profitability dependent on future development outcomes.

Structural Cash Burn

Consistently negative operating and free cash flow means Adocia continues to consume funds to maintain operations and development programs. Even with a narrower operating loss in 2025, ongoing burn can require additional financing and may constrain the pace or scope of future clinical investment.

High Leverage And Volatile Revenue

High debt relative to equity leaves limited balance-sheet cushion if losses continue or financing conditions tighten. The sharp revenue decline after a strong prior year also indicates an uneven partnering or commercialization profile, making funding capacity and financial planning less predictable.

ADOCY FAQ

What was Adocia’s price range in the past 12 months?
Adocia lowest stock price was $2.25 and its highest was $10.44 in the past 12 months.
What is Adocia’s market cap?
Adocia’s market cap is $74.32M.
When is Adocia’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Adocia’s earnings last quarter?
Adocia released its earnings results on Sep 24, 2026. The company reported -$0.501 earnings per share for the quarter.
Is Adocia overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Adocia pay dividends?
Adocia does not currently pay dividends.
What is Adocia’s EPS estimate?
Adocia’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adocia have?
Adocia has 22,007,820 shares outstanding.
What happened to Adocia’s price movement after its last earnings report?
Adocia reported an EPS of -$0.501 in its last earnings report. Following the earnings report the stock price went down -1.464%.
Which hedge fund is a major shareholder of Adocia?
Currently, no hedge funds are holding shares in ADOCY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology